P.N. Durrington

514 total citations
13 papers, 370 citations indexed

About

P.N. Durrington is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P.N. Durrington has authored 13 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P.N. Durrington's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Lipid metabolism and disorders (2 papers). P.N. Durrington is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Lipid metabolism and disorders (2 papers). P.N. Durrington collaborates with scholars based in United Kingdom and United States. P.N. Durrington's co-authors include Michael I. Mackness, Bharti Mackness, Aldons J. Lusis, Alan M. Fogelman, Mohamad Navab, Judith A. Berliner, Gregg C. Fonarow, Diana M. Shih, M. Ishola and M.D. Bastow and has published in prestigious journals such as Heart, Atherosclerosis and Metabolism.

In The Last Decade

P.N. Durrington

12 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.N. Durrington United Kingdom	8	159	114	97	67	49	13	370
Maribel Covas Spain	6	148 0.9×	59 0.5×	55 0.6×	97 1.4×	31 0.6×	6	392
J.P. Charmes France	7	129 0.8×	44 0.4×	29 0.3×	56 0.8×	70 1.4×	13	330
H. Prais United Kingdom	8	60 0.4×	213 1.9×	190 2.0×	36 0.5×	62 1.3×	9	409
Ana Vujović Serbia	10	83 0.5×	106 0.9×	103 1.1×	23 0.3×	44 0.9×	15	369
Dimitra Kalimanovska‐Oštrić Serbia	12	92 0.6×	98 0.9×	54 0.6×	30 0.4×	59 1.2×	36	456
Monica Ishola United Kingdom	8	374 2.4×	153 1.3×	220 2.3×	166 2.5×	79 1.6×	9	678
Rema Mohan India	11	135 0.8×	164 1.4×	244 2.5×	17 0.3×	54 1.1×	17	647
Habibe Genç Türkiye	12	102 0.6×	46 0.4×	30 0.3×	31 0.5×	64 1.3×	17	429
Devika Tayal India	8	100 0.6×	33 0.3×	62 0.6×	32 0.5×	22 0.4×	25	316
Marju Tilly-Kiesi Finland	16	61 0.4×	285 2.5×	348 3.6×	30 0.4×	96 2.0×	23	568

Countries citing papers authored by P.N. Durrington

Since Specialization

Citations

This map shows the geographic impact of P.N. Durrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.N. Durrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.N. Durrington more than expected).

Fields of papers citing papers by P.N. Durrington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.N. Durrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.N. Durrington. The network helps show where P.N. Durrington may publish in the future.

Co-authorship network of co-authors of P.N. Durrington

This figure shows the co-authorship network connecting the top 25 collaborators of P.N. Durrington. A scholar is included among the top collaborators of P.N. Durrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.N. Durrington. P.N. Durrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kwok, See, et al.. (2002). Costs of aspirin and statins in general practice. QJM. 95(1). 23–26. 5 indexed citations

Durrington, P.N. & H. Prais. (2001). Methods for the prediction of coronary heart disease risk. Heart. 85(5). 489–490. 1 indexed citations

Mackness, Michael I., et al.. (1999). Low serum paraoxonase: a risk factor for atherosclerotic disease?. Chemico-Biological Interactions. 119-120. 389–397. 30 indexed citations

Mackness, Michael I., Bharti Mackness, P.N. Durrington, et al.. (1998). Paraoxonase and coronary heart disease. Current Opinion in Lipidology. 9(4). 319–324. 164 indexed citations

Bhatnagar, Deepak & P.N. Durrington. (1993). An evaluation of the Reflotron^® for the determination of plasma cholesterol in capillary blood. Effect of operator variability. Occupational Medicine. 43(2). 69–72. 3 indexed citations

Brown, John H., et al.. (1993). Serum lipoprotein (a) in renal transplant recipients receiving cyclosporin monotherapy. Nephrology Dialysis Transplantation. 8(9). 863–867. 24 indexed citations

Winocour, Peter, P.N. Durrington, Monica Ishola, et al.. (1992). The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in Type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia. Atherosclerosis. 93(1-2). 83–94. 6 indexed citations

Bhatnagar, Deepak & P.N. Durrington. (1990). Coronary Risk Factors: Value of Screening and Preventive Strategies in General Practice. Family Practice. 7(4). 295–300. 1 indexed citations

Winocour, Peter, Lesley Tetlow, P.N. Durrington, et al.. (1989). Apolipoprotein E polymorphism and lipoproteins in insulin-treated diabetes mellitus. Atherosclerosis. 75(2-3). 167–173. 14 indexed citations

10.

Durrington, P.N., et al.. (1989). The Prevalence of Hyperlipidaemia and Related Clinical Features in Insulin-dependent Diabetes Mellitus. QJM. 1(1). 101–117. 27 indexed citations

11.

Bastow, M.D., P.N. Durrington, & M. Ishola. (1988). Hypertriglyceridemia and hyperuricemia: Effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial. Metabolism. 37(3). 217–220. 47 indexed citations

12.

Durrington, P.N., et al.. (1986). Hypertriglyceridaemia and abnormalities of triglyceride catabolism persisting after pancreatitis. International Journal of Pancreatology. 1(3-4). 195–203. 18 indexed citations

13.

Durrington, P.N.. (1979). Effect of Phenobarbitone on Plasma Apolipoprotein B and Plasma High-Density-Lipoprotein Cholesterol in Normal Subjects. Clinical Science. 56(5). 501–504. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact